Sign in
Groups
Researchers
Funding
Results
Jose Luis
Alonso Romero
Asociado Ciencias de la Salud
Fundación Jiménez Díaz
Madrid, España
You are in
Collaborations
Fundación Jiménez Díaz
Publications in collaboration with researchers from Fundación Jiménez Díaz (2)
2022
Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study)
Lung Cancer, Vol. 173, pp. 83-93
2021
Pembrolizumab plus gemcitabine in the subset of triple-negative advanced breast cancer patients in the geicam/2015-04 (Pangea-breast) study
Cancers, Vol. 13, Núm. 21
Contact
Legal notice
translate
en
arrow_drop_down
translate
en
arrow_drop_down
es
ca
eu
gl
fr
de